Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study-Reference-Cited by-同舟云学术

Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study

Published:2019-03-13 Issue:4 Volume:10 Page:904-908
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Fernández‐López Cristina¹^ORCID,Calleja‐Hernández Miguel Ángel²,Balbino Jaime Espín³⁴,Cabeza‐Barrera José⁵,Expósito‐Hernández José⁶

Affiliation:

1. Department of PharmacyVall d'Hebron University Hospital Barcelona Spain

2. Department of Pharmacy, Pharmacy Clinical Management Unit (UGC), Virgen Macarena University Hospital Seville Spain

3. Andalusian School of Public Health (EASP) Granada Spain

4. Health Research Institute of Granada (ibs.GRANADA)University Hospitals of Granada/University of Granada Granada Spain

5. Department of PharmacyBiosanitary Research Institute of Granada, San Cecilio University Hospital Granada Spain

6. Department of OncologyUniversity Hospitals of Granada, Health Research Institute of Granada (ibs.GRANADA) Spain

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13024

Reference21 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Self-Reported Conflicts of Interest of Authors, Trial Sponsorship, and the Interpretation of Editorials and Related Phase III Trials in Oncology

3. Trends in phase III randomized controlled clinical trials on the treatment of advanced non‐small‐cell lung cancer

4. Outcomes and endpoints in cancer trials: bridging the divide

5. American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review;Lung Cancer;2023-03

2. Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1;Acta Oncologica;2021-06-29